Jewett-Cameron Trading Company, the tiny Nasdaq-listed building products firm, enters the final stretch of April with a striking divergence: the stock has put in its best month in recent memory, yet short sellers appear to be quietly walking away.
The price story is the most obvious starting point. JCTC closed at $1.96 on April 29, up nearly 19% over the past month, before slipping half a percent on the final session of the week. The stock has added roughly 1.8% on the week — a modest cap on an otherwise strong run. With a market capitalisation of under $7 million, the name sits firmly in micro-cap territory, where thin liquidity can amplify moves in either direction.
The most dramatic shift has been in the cost to borrow, which tells a story of short sellers retreating rather than pressing. Cost to borrow has collapsed roughly 80% over the past month, from above 13% in late March to 7.2% now. Earlier in March the cost briefly spiked to over 130% — an extraordinary reading that would have made fresh short positions genuinely painful to hold. That spike is now firmly in the rearview mirror. Borrow availability is effectively unlimited at the current level of short interest, with ORTEX reporting availability at 9,999% of SI — meaning the lending pool is nowhere near stressed. Shares short have fallen around 27% over the past month, and short interest as a percentage of free float is a negligible 0.38%. With days to cover at just 0.26, there is no meaningful short squeeze dynamic in the current setup.
The ORTEX short score of 28.2 confirms the picture: this is not a name where short sellers are aggressively building. The short score rank sits at 82 out of 100 relative to peers, which reflects the historical positioning context more than the current pressure — the score has drifted slightly lower across the past two weeks, from 29.8 on April 15 to 28.2 now. Utilisation — the proportion of available shares actually on loan — is running at just over 1%, a fraction of the 6.6% peak recorded at some point in the past year. The lending market, in short, has largely normalised.
The one genuinely notable ownership angle involves the Oregon Community Foundation, which holds roughly 21.7% of shares — the dominant institutional position by far. The Foundation ran a steady programme of small sales through February, trimming around 63,000 shares across multiple transactions at prices between $1.78 and $1.81. Those sales have since stopped appearing in the data, with the last reported trade on February 26. Whether the selling has paused or simply hasn't yet been reported is worth monitoring. Renaissance Technologies also holds a 2.6% position but trimmed it slightly at year-end 2025. No insider purchases appear in the record.
There are no analyst ratings or price targets to report for JCTC — the stock has no sell-side coverage in the ORTEX dataset. Valuation data is stale, with the most recent figures dating to August 2025. The RSI14 sits at 62, a mildly elevated reading that reflects the month's strong performance without flagging overbought conditions. The next scheduled earnings event is July 10, which is the natural near-term marker for the stock.
The key thread to watch is whether the Oregon Community Foundation resumes selling near current prices. The stock has recovered well above the levels at which those February disposals took place, and any resumption of that programme would represent consistent supply into the recent strength.
See the live data behind this article on ORTEX.
Open JCTC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
